Pascal Juillerat MD MSc, IBD specialist retweeted
Great lucter abt Acute Severe & Fulminant Colitis by @PascalJuillerat
Masterclass in IBD 💚
supervised by @DignassAxel & Stephan Vavricka
@my_ueg EDUCATION 💙
Vienna 🎡 2025
#UEG 💜 #IBD #UC #ASCU
. – at Vienna, Austria
Pascal Juillerat MD MSc, IBD specialist retweeted
🤩 exciting days ahead
Replying to @my_ueg
Course Directors: @DignassAxel, @VavrickaStephan
Faculty: @ign76, @Bealoquebea, @DrAilsaHart, @PascalJuillerat, Bel Klaartje Kok, James Lindsay, @PMyrelid, @edyta_tul, @bverstockt
Pascal Juillerat MD MSc, IBD specialist retweeted
Great talk by Bel Kok regarding disease monitoring in IBD at @my_ueg IBD masterclass
Pascal Juillerat MD MSc, IBD specialist retweeted
Course Directors: @DignassAxel, @VavrickaStephan
Faculty: @ign76, @Bealoquebea, @DrAilsaHart, @PascalJuillerat, Bel Klaartje Kok, James Lindsay, @PMyrelid, @edyta_tul, @bverstockt
Pascal Juillerat MD MSc, IBD specialist retweeted
AGA 2025 clinical practice guidelines for Crohn’s disease 📌🆕
📸: gastrojournal.org/action/sho…
Pascal Juillerat MD MSc, IBD specialist retweeted
'Free to read' via bit.ly/45GWWRG
"Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease"
by Mahadevan et al
#IBD #GItwitter #pregnancy
Pascal Juillerat MD MSc, IBD specialist retweeted
We’re pleased to announce the “ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with IBD,” a project involving IBUS, showing the role of IUS in the diagnosis and monitoring of IBD patients.
P.1: 10.1093/ecco-jcc/jjaf106
P.2: 10.1093/ecco-jcc/jjaf107
Pascal Juillerat MD MSc, IBD specialist retweeted
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…
Pascal Juillerat MD MSc, IBD specialist retweeted
Just Starting 4th Postgraduate Course #ECCO2025 #EDUCOM course with more than 350 attendees!
@UriKopylov @FernandoMagro6 with and a amazing talk from @SeverineVermei1
Pascal Juillerat MD MSc, IBD specialist retweeted
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial ➡️ ow.ly/qY1950UX0ZO
Pascal Juillerat MD MSc, IBD specialist retweeted
Just published in the American Journal of Therapeutics 🔥
JAKi in Chronic Inflammatory Pouch Conditions:
📌Clinical response: 43%
📌Endoscopic response: 48%
📌AEs: 16%
📌Primary treatment failure: 42%
📊JAKi are not recommended to be first line treatment in chronic pouch conditions ✔️
@JHashashMD @fouadsjaber @YazanAbboudMD @CrohnsColitisFn #GITwitter #IBD @MondayNightIBD
Pascal Juillerat MD MSc, IBD specialist retweeted
How can you not love Charles Bernstein ? Amazing career as a clinician scientist for over 30 years!!! Linking the learnings from IBD epidemiology to climate inform clinical practice @gilkaplan @EdwardLoftus2
Pascal Juillerat MD MSc, IBD specialist retweeted
#ECCO UC Treatment Guideline Update - how it started...
@bverstockt @HolubarStefan @RajaAtreya @I_Blumenstein @AlaaEl_Hussuna @manu_barreiro @AnthonydeBuck @fgomollon @Max_Fantini @fede__furfaro @MariangelaAllo3 @PascalJuillerat @mjosecasanova @UriKopylov @EderPiotr et al.
#IBD
Pascal Juillerat MD MSc, IBD specialist retweeted
IBD Monitoring how&when. Tandem talk with #HagarBanaiEran from #rabinhospitalpetahtikva at #FalkSymposium238 in Florence. @HUNIMED
Pascal Juillerat MD MSc, IBD specialist retweeted
🌟 Making a choice of therapy for IBD
Take into account extraintestinal concerns as well as contraindications to treatment!
🙏🏻 @IBDMD
#GITwitter #ACG2024 @AmCollegeGastro
Pascal Juillerat MD MSc, IBD specialist retweeted
Nobel Prize winning concepts land in IBD. The discovery of power and importance of microRNA biology . @bruce_sands1 presenting the long term results of the phase 2a Obefazimod UC. Study . Is this the game changer? Calling all investigators . We need to get the phase III DONE !!!
Pascal Juillerat MD MSc, IBD specialist retweeted
New online! Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease go.nature.com/3YeNfpz
Pascal Juillerat MD MSc, IBD specialist retweeted
"Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases" free to read at bit.ly/3ZXdgeo
#GItwitter #IBD #consensus
Pascal Juillerat MD MSc, IBD specialist retweeted
The 2024 #NobelPrize in Physiology or Medicine focuses on the discovery of a vital regulatory mechanism used in cells to control gene activity. Genetic information flows from DNA to messenger RNA (mRNA), via a process called transcription, and then on to the cellular machinery for protein production. There, mRNAs are translated so that proteins are made according to the genetic instructions stored in DNA. Since the mid-20th century, several of the most fundamental scientific discoveries have explained how these processes work.
In 1993, this year's Nobel Prize laureates published unexpected findings describing a new level of gene regulation, which turned out to be highly significant and conserved throughout evolution. They discovered microRNA, a new class of tiny RNA molecules that play a crucial role in gene regulation.
Read more: bit.ly/4dlPE6f






















































